Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
Yu
S K T
SK
Chalmers
A J
AJ
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D019072:Antibiotic Prophylaxis; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000209:etiology*; D018570:Risk Assessment; D012307:Risk Factors; D000077204:Temozolomide
D000305:Adrenal Cortex Hormones; D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide